Which university are you at? http://madthumbs.fun/ madthumbs Some Elan investors have speculated that any of the industry buyers could acquire Elan and sell a portion of the royalties on the drugmaker's multiple sclerosis drug Tysabri to Royalty Pharma, which is what the investment firm has wanted all along.
 |
ケータイからも利用可能。同じアドレスにアクセス。
